Clinical trial
A Genome-Wide Scan For Quantitative Trait Loci of Serum Bilirubin - A Framingham…
NCT00340509 · National Heart, Lung, and Blood Institute (NHLBI), NIH · Completed
Key facts
| NCT number | NCT00340509 |
|---|---|
| Title | A Genome-Wide Scan For Quantitative Trait Loci of Serum Bilirubin - A Framingham Study |
| Official title | A Genome-Wide Scan For Quantitative Trait Loci of Serum Bilirubin - A Framingham Study |
| Lead sponsor | National Heart, Lung, and Blood Institute (NHLBI), NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Genetics |
| Enrollment | 1,888 |
| Start date | Oct 26, 2001 |
| Completion | Jul 23, 2013 |
| First posted | Jun 21, 2006 |
| Last update posted | Dec 16, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: